1,029 filings
Page 29 of 52
8-K
e8up mxdq30ws3yzl
26 Jun 17
Trovagene Announces Expansion of Key Claims for its NPM1 Patent Portfolio for Acute Myeloid Leukemia
12:00am
8-K/A
mojf7
23 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
7j66b2p8bu
23 Jun 17
Other Events
12:00am
8-K
bh4bzrt0x
22 Jun 17
Trovagene Announces Agreement with Global Biopharmaceutical Company to Utilize Trovera® ctDNA Tests and Services in Cancer Clinical Trials
12:00am
8-K
21yaib6
13 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ta8gydn xc8aftxu
12 Jun 17
Trovagene Enters Into Agreement with AstraZeneca to Utilize Trovera® ctDNA Test and Services in Prospective Biomarker Study
12:00am
8-K
qvg87d6ei4fno5n agzl
7 Jun 17
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
12:00am
8-K
tto00 wghong1ka
2 Jun 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
25-NSE
7tsno n2euhcroc35
30 May 17
Exchange delisting
12:00am
8-K
m7ps5
25 May 17
Phase 1 Safety Study Supports Planned Development of PCM-075 in AML
12:00am
8-K
6jrq dn1hdinl
23 May 17
Other Events
12:00am
CT ORDER
nyqoua6
19 May 17
Confidential treatment order
12:00am
8-K
slzkz7
10 May 17
Trovagene Announces First Quarter 2017 Company Highlights and Financial Results
12:00am
8-K
si9p3swdxd1dg5pq8lm
1 May 17
Regulation FD Disclosure
12:00am
DEFA14A
1lyjlndi8
28 Apr 17
Additional proxy soliciting materials
12:00am
8-K
0fkz gwavvlh9
26 Apr 17
Other Events
12:00am
8-K
g97q5oh1sctydeno
25 Apr 17
Other Events
12:00am
8-K
vf9l g9578ov
14 Apr 17
Trovagene Announces the Addition of Dr. Sandra Silberman to its Clinical Advisory Board
12:00am